CanadaFemyso Mifepristone 200 mg / Misoprostol 200 mcg tablet kits (Lupin Pharma Canada Ltd., DIN 02560569, lot NR02557A) may contain two green mifepristone cartons or two pink misoprostol cartons instead of one of each. The product is being recalled because the affected lot may contain duplicate cartons; verify whether your product is affected, consult your healthcare provider before discontinuing use or if you have health concerns, contact Lupin Pharma Canada Limited with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Lupin Pharma Canada Limited., 550-1111 rue St-Charles Ouest, Longueuil, QC, J4K 5G4.
How to identify it
Brand: Lupin Pharma Canada Ltd.; Product Name: Femyso Mifepristone 200 mg / Misoprostol 200 mcg tablet; Market Authorization: DIN 02560569; Dosage Form: Kit, Tablet; Strength: Mifepristone 200 mg / Misoprostol 200 mcg; Lot Number: NR02557A
The hazard
Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.
What to do
Verify whether your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or if you have any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)